stoxline Quote Chart Rank Option Currency Glossary
Clearmind Medicine Inc. (CMND)
3.3399  0.331 (11%)    11-28 14:54
Open: 3.27
High: 4.7499
Volume: 3,511,567
Pre. Close: 3.009
Low: 2.5208
Market Cap: 49(M)
Technical analysis
2023-11-28 2:17:10 PM
Short term     
Mid term     
Targets 6-month :  5.54 1-year :  6.47
Resists First :  4.74 Second :  5.54
Pivot price 0.33
Supports First :  1.87 Second :  0.1
MAs MA(5) :  0.74 MA(20) :  0.28
MA(100) :  0.31 MA(250) :  1.44
MACD MACD :  0.2 Signal :  0
%K %D K(14,3) :  29.8 D(3) :  21.6
RSI RSI(14): 97.8
52-week High :  5.09 Low :  0.1
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ CMND ] has closed above the upper band by 43.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 1959.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.12 - 0.12 0.12 - 0.12
Low: 0.1 - 0.1 0.1 - 0.1
Close: 0.1 - 0.1 0.1 - 0.1
Company Description

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Headline News

Tue, 28 Nov 2023
Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment - Yahoo Finance

Tue, 28 Nov 2023
Clearmind Medicine (NASDAQ: CMND) to rise 3,000% today - purely technical - Dhaka Tribune

Mon, 27 Nov 2023
Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures - Yahoo Finance

Mon, 27 Nov 2023
Why UP Fintech Shares Are Trading Higher By Around 7%; Here ... - UK

Tue, 21 Nov 2023
Clearmind Medicine Announces 1-for-30 Reverse Share Split - Yahoo Finance

Fri, 17 Nov 2023
Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 15 (M)
Shares Float 6 (M)
Held by Insiders 7.4 (%)
Held by Institutions 3.1 (%)
Shares Short 322 (K)
Shares Short P.Month 145 (K)
Stock Financials
EPS -3.01
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.4
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -138.9 %
Return on Equity (ttm) -409.9 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.41
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio -1.09
PEG Ratio 0
Price to Book value 8.15
Price to Sales 0
Price to Cash Flow -8.11
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android